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httpLeveraging the electronic medical record to
implement an abdominal aortic aneurysm
screening program
Robert J. Hye, MD,a Andrea E. Smith, MSN, RN, PHN,b Gary H. Wong, MD, MPH,c
Southida S. Vansomphone, PharmD,d Ronald D. Scott, MD,e and Michael H. Kanter, MD,f San Diego,
Pasadena, Fontana, Downey, and West Los Angeles, Calif
Objective: Screening for abdominal aortic aneurysms (AAAs) reduces aneurysm-relatedmortality and has been recommended
by the U.S. Preventive Services Task Force and American Heart Association since 2005. Medicare has covered a one-time
screening ultrasound for new male enrollees with a familial or smoking history since 2007. Nevertheless, in the U.S.,
screening has remained underutilized. Review of patients with rupturedAAA in our system in 2007 showed themajoritywere
undiagnosed, yetmetU.S.Preventive ServicesTaskForce andAmericanHeartAssociation screeningguidelines. To reduce the
number of preventable AAA ruptures and deaths in our patients, we implemented an AAA screening program using our
electronicmedical record (EMR).This studydescribes the design, implementation, and early results of that screeningprogram.
Methods: Between March 2012 and June 2013, men aged 65 to 75 years with any history of smoking were targeted for
screening. Medical records were reviewed electronically to exclude patients with abdominal imaging studies within
10 years that would have diagnosed an AAA. Best practice alerts (BPA) were created in the EMR so when an appropriate
patient is seen, ofﬁce staff and providers are prompted to order an aortic ultrasound. AAA was deﬁned as aortic diameter
$3.0 cm or greater, and ultrasound reports contained a standard template providing guidance for patient management
when an aneurysm was identiﬁed. Newly identiﬁed AAAs were triaged for vascular surgery consultation or follow-up with
their primary physician. The number of eligible patients, unscreened patients, and AAAs identiﬁed were tabulated by our
Regional Outpatient Safety Net Program.
Results: In a population of 3.6 million, 55,610 patients initially met screening criteria, and 26,837 (48.26%) were
excluded from the BPA because of prior abdominal imaging studies. After 15 months, there were 68,164 patients who
met screening criteria, 54,356 (79.74%) of whom had undergone an abdominal imaging study. Thus, 27,519 patients
underwent an imaging study after the BPA was activated. During the study period, 731 new AAAs were diagnosed, 165
over 4.0 cm in diameter. Screening rates have increased at all medical centers where the BPA was activated, and the
percentage of unscreened patients has been reduced from 51.74% to 20.26% system-wide.
Conclusions: In an integrated health care system using an EMR, AAA screening can be implemented with a dramatic
reduction in unscreened patients. Further analysis is required to assess the impact of the screening program on AAA
rupture rate and cost-effectiveness in our system. (J Vasc Surg 2014;59:1535-43.)Death due to rupture of abdominal aortic aneurysm
(AAA) occurs in approximately 10,000 patients in the
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://dx.doi.org/10.1016/j.jvs.2013.12.016asymptomatic until shortly before rupture, making detec-
tion and repair prior to the event the most effective means
of reducing aneurysm-related morbidity and mortality. In
most patients, screening with simple abdominal ultrasound
will identify an AAA and is a non-invasive, cost-effective
technique that has been shown in several studies to reduce
AAA-related mortality in at risk populations.2-5 Based on
this evidence, since 2005, the U.S. Preventive Services
Task Force (USPSTF) and the American Heart Association
(AHA) have recommended screening in men aged 65 to
75 years of age with any history of smoking.6,7 More recent
follow-up studies of the screened populations have demon-
strated long term reduction in AAA-related mortality,
all-cause mortality, and cumulative cost-effectiveness asso-
ciated with AAA screening.8-10 Screening guidelines have
been proposed by multiple additional groups but are
generally broader in scope and have used less rigorous
methodology.11
Evidence for the efﬁcacy of screening combined with
the recommendations above led to the passage of the
Screen for Abdominal Aortic Aneurysms Very Efﬁciently
(SAAAVE) Act by the Federal Government.12 This law,1535
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screening exam for new male Medicare enrollees with a his-
tory of smoking more than 100 cigarettes and for females
with a family history of AAA disease. No similar beneﬁt
was extended for existing Medicare participants. At about
the same time, The Department of Veterans Affairs (VA)
also mandated a system-wide screening program to include
all eligible patients, not just new enrollees. For a variety of
reasons, neither of these federal programs appears to have
been effective in achieving their goal of screening high
volumes of the target population, and it is estimated that
less than 15% of eligible Medicare patients are being
screened.13,14
While screening and identiﬁcation of the patient with
an AAA is the most critical aspect in reducing morbidity
and mortality associated with ruptured AAA, most of the
AAAs that are found will be small and not require immedi-
ate repair. Therefore, any screening program must also
have an equally effective tracking mechanism so that pa-
tients can be followed and scheduled to undergo reimaging
at appropriate intervals.
The computerized electronic medical record (EMR)
has the potential to enhance screening programs by allow-
ing rapid review of demographics, risk factors, and prior im-
aging studies to separate those in need of screening from
those with an already known diagnosis or adequate previous
imaging exams that would exclude the diagnosis. Addition-
ally, clinical reminders can be generated to prompt clinicians
to order appropriate studies when indicated, and patients
can be effectively tracked over time. Several small series
have reported the utility of the EMR in AAA screening,
including the VA Healthcare System in this country, and
it has been suggested that other systems with a developed
EMR should consider using it for screening.15-17
Kaiser Permanente (KP) is an integrated health care
organization that cares for over 9 million patients nation-
wide, 3.6 million in Southern California. There is a strong
history of practicing high quality preventive care and popu-
lation based medicine.18,19 In 2007, AAA-related mortality
was reviewed in KP Southern California, and it was deter-
mined that the number of ruptured AAAs in our patient
population was higher than was desired, given that there
was evidence that screening can reduce AAA-related mor-
tality. Review of the cases revealed that the majority of
patients presenting with ruptured AAA had not been
known to have an aneurysm. A small but not insigniﬁcant
minority of cases were noted in patients with known AAA
that had been lost to follow-up, refused surgery, or were
felt to be too high risk for repair. Although clinical practice
guidelines for screening were already in place in our system,
they were not being adequately followed. On the basis of
the 2007 review, the vascular surgery divisions, in conjunc-
tion with regional leadership, developed plans to imple-
ment a more effective screening program for AAAs.
During 2005 and 2006, a comprehensive EMR had been
implemented throughout all of KP’s outpatient and inpa-
tient facilities. The EMR contains a robust ability to provide
clinical reminders to practitioners for a variety of clinicalconditions during patient visits and was identiﬁed as the
ideal mechanism to improve screening within our health
care system. Concomitantly, it was decided to use an exist-
ing outpatient safety net program, designed to prevent loss
of patients with chronic conditions to follow-up, to track
the small and unrepaired AAA patient population. This pa-
per describes the development of the screening and
tracking program, as well as the early results of these efforts.
METHODS
Based on USPSTF and AHA guidelines, male patients
between the ages of 65 and 75 years with any history of
current or past smoking were selected as the target popula-
tion. Review of existing databases and charts of all patients
included in the study was conducted under a protocol
approved by the Institutional Review Board of Kaiser Per-
manente Southern California. To avoid unnecessary
ordering of screening exams, it was assumed that patients
with known or repaired AAAs would likely have had an
abdominal imaging study within the past 10 years. It was
also assumed that if a patient had an abdominal imaging
study within 10 years and was not diagnosed with an
AAA, then screening was not required. Therefore, we
selected patients in the target population for screening
who had no record of an abdominal imaging study in the
past 10 years (Table I). KP uses a tool called the “Proactive
Ofﬁce Encounter” (POE) where ofﬁce nursing staff see a
list of “care gaps” when patients are seen in the ofﬁce.20
The POE is proprietary software developed by KP that ex-
tracts data from the EMR and processes it further. Identi-
ﬁcation of these care gaps prompts the staff to remind
patients to follow-up on previously ordered tests or to assist
patients in scheduling screening exams such as mammog-
raphy or blood tests when indicated. A “Best Practice
Alert” (BPA) was created within the EMR as part of the
POE process that would be visible to the nursing staff
when patients in need of AAA screening were checked in
for visits with a practitioner. This allowed the staff to enter
an order for a screening aortic ultrasound that the clinician
could then sign when signing any orders for the patient at
the time of closing the chart (Fig 1).
An aortic diameter of $3.0 cm was used as the deﬁni-
tion of an AAA, and an aortic diameter of 2.5 to 2.9 cm
was considered aortic ectasia. Included at the end of the
report for all aortic ultrasounds or other imaging studies
demonstrating an aortic aneurysm in our organization is
a follow-up algorithm for AAA management (Fig 2). An
additional beneﬁt of the EMR is that it allows the physician
to easily order follow-up imaging studies at speciﬁed inter-
vals up to 36 months in advance.
KP in Southern California has had a Regional Outpa-
tient Safety Net (ROSN) program since 2009. The
ROSN is a program that capitalizes on the EMR to system-
atically identify members who have inadvertent lapses in
care using a small, centralized team to intervene before
the patient experiences any harm. It was elected to place re-
sponsibility for oversight of the tracking component of the
screening program in this department. The EMR is
Fig 1. Screen shot of “Best Practice Alert” (BPA) used in the electronic medical record (EMR) to notify ofﬁce staff
that screening abdominal aortic aneurysm (AAA) ultrasound should be ordered.
Table I. Current Procedural Terminology (CPT) imaging codes used to exclude patients from screening best practice
alert (BPA)
CPT code Description
72131 CMPT TOMOGRPH LUMBAR SPINE; W/O CONTRST MATERIAL
72132 CMPT TOMOGRAPHY LUMBAR SPINE; W/CONTRST MATERIAL
72133 CT LUMB SPN; W/O & W/CONTRST & OTH SECT
72148 MR IMAG SP CANAL&CONTENTS LUMB; W/O CONTRST MATL
72149 MR IMAG SP CANAL&CONTENTS LUMB; W/CONTRST MATL
72158 MRI SPINAL CANAL W/O THEN W/CONTRAST; LUMBAR
74150 CMPT TOMOGRAPHY ABD; WITHOUT CONTRST MATERIAL
74160 CMPT TOMOGRAPHY ABDOMEN; W/CONTRAST MATERIAL
74170 CT ABD; W/O CONTRST FLW CONTRST&FURTHER SECT
74175 CT ANGIOGRAPHY ABDOMEN W/CONTRAST/NONCONTRAST
74176 CT ABD & PELVIS W/O CONTRAST
74177 CT ABD & PELVIS W/CONTRAST
74178 CT ABD & PELVIS W/O CONTRST 1þ BODY REGNS
74181 MR IMAGING ABDOMEN; WITHOUT CONTRAST MATERIAL
74182 MR IMAGING ABDOMEN; WITH CONTRAST MATERIAL
74183 MRI ABD W/O & W/CONTRAST & FURTHER SEQUENCES
74185 MRA ABD Cþ-MATRL
76700 US ABDOMINAL R-T W/IMAGE DOCUMENTATION
93975 DUPLEX SCAN IN-OUTFLO ABD/PELV ORGAN; CMPL STDY
93978 DUPLEX SCAN OF AORTA, INFERIOR VENA CAVA, ILIAC VASCULATURE, OR BYPASS GRAFTS;
COMPLETE STUDY
93979 UNILATERAL OR LIMITED STUDY
74174 COMPUTED TOMOGRAPHIC ANGIOGRAPHY ANGIOGRAPHY, ABDOMEN AND PELVIS, WITH
CONTRAST MATERIAL(S), INCLUDING NONCONTRAST IMAGES
ABD, Abdomen; CMPL, complete; CMPT, computed; CONTRST, contrast; CT, computed tomography; Cþ-MATRL, with contrast material; FLW, fol-
lowed by; IMAG, image; IN-OUTFLO, inﬂow and outﬂow; LUMB, lumbar; MR, magnetic resonance; MRA, magnetic resonance angiography; MRI,
magnetic resonance imaging; OTH, other; PELV, pelvis; REGNS, regions; R-T, real time; SECT, section; SP, spinal; SPN, spine; TOMOGRAPH, tomography;
W/O, without; W/, with.
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of AAA (Table II), as well as the follow-up imaging studies
and vascular surgery consultations that they may have had.
The data is refreshed monthly to capture newly diagnosed
patients and the most recent follow-up (imaging and
vascular surgery consultations). When no follow-up has
been detected for 12 months in the EMR, the ROSN
registered nurse reviews the chart of each patient and
documents the size of the AAA. For patients with aortic
diameters of 3.0 to 3.9 cm, the nurse places an order to
be co-signed by the primary care physician for a follow-
up ultrasound of the abdominal aorta. For aortic diameters
of 4.0 to 5.9 cm, a routine vascular surgery consultation
is generated, and if the aortic diameter is $6.0 cm, an
urgent vascular surgery consultation (within 1 week in theabsence of symptoms) is requested. For patients diagnosed
with aortic ectasia (aortic diameter 2.5 to 2.9 cm), appro-
priate follow-up and risk factor modiﬁcation is conﬁrmed,
with notiﬁcation of the patient’s primary physician as
required.TheROSNprogramdoes not bear primary respon-
sibility for patient tracking but functions in the background
to verify that appropriate follow-up is being performed.
The BPA was activated in March of 2012 in 10 of 13
of our medical centers. Two centers were activated about
8 months and 12 months later, while one remains unacti-
vated. Analysis of the results of screening was conducted
between March, 2012 and June, 2013. The number of
patients in the target population, the number with
abdominal imaging studies, and the total number and
sizes of new AAAs diagnosed were tabulated quarterly.
Fig 2. Abdominal aortic aneurysm (AAA) management guidelines appended to each aortic ultrasound report or other
imaging report showing AAA in Kaiser Permanente (KP) Southern California. CVD, Cardiovascular disease; SCPMG,
Southern California Permanente Medical Group.
Table II. International Classiﬁcation of Diseases, Ninth
Edition (ICD-9) codes tracked by Regional Outpatient
Safety Net (ROSN) Program
ICD-9
code ICD-9 description
441.4 ABDOMINAL ANEURYSM WITHOUT
MENTION OF RUPTURE
441.7 THORACOABD ANEURYSM WITHOUT
MENTION RUPTURE
441.9 AORTIC ANEUR UNSPEC SITE WITHOUT
MENTION RUPTURE
441.4B ANEURYSM, SUPRARENAL AORTA
441.4C ANEURYSM, SUPRACELIAC AORTA
441.4D ANEURYSM, ABDOMINAL AORTA
441.4E ANEURYSM, ABDOMINAL AORTA,
ENLARGING
441.4H ANEURYSM, AORTIC, ABDOMINAL (AAA),
CURRENT W/O RUPTURE
441.4I ABDOMINAL AORTIC ANEURYSM >39 MM
441.4J ABDOMINAL AORTIC ANEURYSM 35-39 MM
441.4K ABDOMINAL AORTIC ANEURYSM 30-34 MM
441.7B ANEURYSM, THORACOABDOMINAL AORTA
441.9D ANEURYSM, AORTA
AAA, Abdominal aortic aneurysm; ANEUR, aneurysm; MM, millimeter;
THORACOABD, thoracoabdominal;UNSPEC, unspeciﬁed;W/O, without.
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patients at each medical center was also monitored and
recorded quarterly.
RESULTS
When the program was activated in KP Southern
California in March 2012, there were a total of 55,610 pa-
tients within the target population. Of this group, 26,837
(48.26%) were identiﬁed as having an abdominal imagingstudy in the past 10 years, leaving 28,733 (51.74%) who
required screening. For this group, the BPA was activated
within the POE so that practitioners would be prompted
to order an aortic ultrasound during clinic visits. By the
end of June, 2013, a total of 68,164 patients were identi-
ﬁed within the study group, and 54,356 (79.74%) had un-
dergone abdominal imaging, including the 26,837 initially
excluded from ﬁring of the BPA, leaving only 13,808
(20.26%) unscreened. The relatively large increase in the
target population is believed to be due to a combination
of an absolute increase in the population and improved
capture of smoking history. Following activation of the
BPA, there was a dramatic (seven-fold over 5 months) in-
crease in the number of aortic ultrasound requests being
made to our departments of radiology, overwhelming
some of them with volume in the short term. Concomi-
tantly, there was both a large increase in queries to vascular
surgery regarding small aneurysm management and refer-
rals to vascular surgery for evaluation of AAAs in general.
These increased volumes were absorbed into the system
by committed and innovative work on the part of our radi-
ology departments, radiologists, and vascular surgeons, and
volumes are now at a more consistent baseline.
During the 15 months of the study, there was a marked
decrease in the number of unscreened patients in our sys-
tem, with an aggregate regional decline in unscreened
patients from 51.74% to 20.26% (Fig 3). The effectiveness
of the EMR prompts is highlighted by the marked differ-
ence in the percentage of unscreened patients in the three
medical centers where BPA activation was delayed or did
not occur. In centers where the BPA was activated, the
rate of decrease in unscreened patients was remarkably
similar. During the study period, 731 new diagnoses of
AAAs were made in KP Southern California, with a typical
Fig 3. Cumulative percentage of patients having undergone an abdominal imaging study within 10 years by medical
center. The best practice alert (BPA) was activated in the ﬁrst quarter of 2012 (Y12Q1) in 10 of 13 medical centers, and
a marked increase in percentage of screened patients was noted. Activation of the BPA was delayed in medical centers
2 and 7, and center 5 has not been activated. AAA, Abdominal aortic aneurysm.
Table III. Number and size of new abdominal aortic
aneurysms (AAAs) diagnosed over 15 months of
screening program
AAA size No.
Total 731
3.0 to 3.9 cm 566
4.0 to 4.9 cm 119
5.0 to 5.9 cm 28
$6.0 cm 18
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the majority of the aneurysms are small and are now being
followed by the patient’s primary physicians with back-up
from the ROSN program. These newly diagnosed aneu-
rysms were found not only through the screening program,
but were also incidental ﬁndings on other abdominal imag-
ing studies or were diagnosed as a consequence of imaging
studies ordered by practitioners who suspected the pres-
ence of an aneurysm. Our present system does not allow
us to determine how many of the AAAs were discoveredsolely through the screening process. Although the prepon-
derance of AAAswere small, 165 (22.6%) were of a sizemer-
iting referral for vascular surgery consultation and possible
repair in appropriate risk patients with larger aneurysms.
The precise cost of the program was not determined,
but the estimated cost of the additional ultrasound studies
and administrative overhead in the ﬁrst year was about $3
million, with <10% due to personnel expenditures. We es-
timate annual future costs to be about 50% of the ﬁrst year
ﬁgure.
DISCUSSION
Screening for AAAs has been shown to be effective in
reducing aneurysm-related mortality and all-cause mor-
tality in populations where it has been employed.2-5,8-10
AAA screening has also been shown to be equally or
even more cost-effective than other widely accepted
screening programs such as for colon and breast cancer.3,8
Nevertheless, despite federal legislation to promote and
pay for the cost, screening for AAAs has not been broadly
implemented in the U.S. The cause of this is multi-
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care system, provision for screening only at the time of
Medicare enrollment, dependence on individual physi-
cians to be aware of and order the screening studies, and
lack of awareness on the part of the public of AAA disease
and its risk factors. The SAAAVE act does not provide a
mechanism for direct patient notiﬁcation regarding the
option of having a screening ultrasound if they are in an
at-risk population. Although the National Committee
for Quality Assurance requires public reporting on a vari-
ety of cardiovascular metrics, reporting of AAA screening
rates is not a requirement.
An EMR utilized in an integrated health care system
provides an ideal opportunity to establish an effective
screening and tracking program with the potential to
reduce aneurysm-related morbidity and mortality.
Leveraging of these electronic assets also allows the pro-
gram to be established and operate with relatively little in
the way of additional human administrative resources.
The experience in KP Southern California using the
EMR to facilitate implementation of an AAA screening
program clearly shows the effectiveness of this approach. It
should be noted that, since the vast majority of the Medicare
population in KP is capitated, the provisions of the
SAAAVE Act were not an incentive and did not impact
our ability to implement an effective screening program.
Within 15 months of beginning our screening program,
the percentage/number of unscreened patients has fallen
from 51.74% to 20.26%. Additionally, 731 new AAAs have
been detected. Of course, the most important impact of an
AAA screening program is to reduce the number of ruptured
AAAs in a population. At this point, we have not analyzed
the impact of our screening program on the AAA rupture
rate in our system, but that analysis is planned after the pro-
gram has been in place for a longer period of time.
Kaiser Permanente has some additional unique charac-
teristics that may make it difﬁcult to duplicate these results
in other environments. First, the EMR is in use throughout
all inpatient and outpatient facilities in the system so that all
practitioners have readily available access to the patient’s
complete medical record and clinical reminders, regardless
of geographic location. When the back ofﬁce staff enters an
order via the POE process, the practitioner can respond
easily and quickly by simply signing the order for the
screening study. In contrast, the system reported on by
Meyer et al17 depended on the individual practitioner initi-
ating the order. We believe this difference is responsible for
the high success rate observed in our study. In addition,
our group has been very selective in using BPAs within
the POE to avoid desensitizing the staff to the importance
of the alert. Finally, our medical group is comprised almost
solely of full-time partners of the Southern California Per-
manente Medical Group. There is a strong culture within
the group of providing preventive care on the basis of
evidence-based medicine, and compliance with suggestions
to take action via a clinical reminder is high.
Another unique and useful aspect of using the EMR for
this program is the ability to provide immediate feedback tothe primary physician regarding follow-up for these patients.
When a screening ultrasound detects an AAA, an “abnormal
results” alert is triggered by the reading radiologist for the
physician to review the study result. The report contains
our AAA follow-up guidelines that provide the physician
with immediate information on how to respond and
schedule the appropriate follow-up. The ROSN provides a
back-up system to verify that follow-up is occurring.
There are a number of weaknesses in the approach that
we have taken that should be highlighted. These deﬁciencies
were recognized at the time we began the screening pro-
gram, but the philosophy was to rapidly implement a pro-
gram that could be improved in the future rather than
delaying implementation in order to design a perfect pro-
gram.We felt this approach would allow increased detection
of additional patients with AAAs in our system immediately.
First, we elected to include only 65- to 75-year-old males
with a history of smoking in the target population, excluding
women, non-smokers, and patients with a positive family
history. While this is consistent with USPSTF and AHA rec-
ommendations, others have elected or advocated a broader
approach.11,21,22 In the interest of cost-effectiveness and
to avoid overwhelming our imaging services, we chose to
exclude patients from the screening program if they
had an abdominal imaging study within the past 10 years.
Neither the reports nor the studies themselves were re-
viewed to conﬁrm the absence of an aneurysm. It is known
that even when an AAA is reported in the results of an imag-
ing study that the information is often not recorded in the
patient’s chart, even when an EMR is in use. One study
showed that 58% of aortic dilations noted on a computed to-
mography scan were not recorded in the chart within
3 months, and 29% were never recorded.23 Therefore, there
are possibly some patients in our population that were
excluded on the basis of imaging criteria who have aneu-
rysms. Fortunately, natural language processing software is
improving and is an adjunct that will allow review of those
patient’s medical records in the future and help identify pa-
tients that may have been missed.
The AAA screening program that was instituted also
did not include outreach to patients via mail, phone, or
e-mail but instead was based on use of the clinical reminder
during patient encounters. Therefore, patients who do not
have any encounters with a medical practitioner are not
presently offered screening in our program. This deﬁciency
would be easily remediable in the future.
Recent reports have also shown that a small but signiﬁ-
cant number of patients who have aortic dilation but whose
aortic diameters that do not meet our 3.0 cm threshold will
be found to have AAA or even rupture when followed long-
term. In the Multicentre Aneurysm Screening Study
(MASS) study, a threshold of 3.0 cm was also used, and
AAA ruptures in the “normal” aortic diameter group began
to increase after 8 years of follow-up, with half of the rup-
tures occurring in patients who had aortic diameters
between 2.5 and 2.9 at the time of initial screening.10
A meta-analysis of patients with aortic diameters of 2.5 to
2.9 cm in eight screening studies showed progression to
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years of follow-up.24 Finally, in the Gloucestershire study,
patients with aortic diameter $2.6 cm were included in
the surveillance group, and over a 10-year period, 15%
developed an AAA >5.4 cm.9 Interestingly, a decline in
the overall incidence of AAAs and aortic diameter over the
20 years of the studywas also noted. InKP SouthernCalifor-
nia, we have emphasized reporting and coding of members
with aortic diameters of 2.5 to 2.9 cm as “aortic ectasia.”
The presence of this code on the patient’s problem list serves
as a reminder to the primary physician to be vigilant
regarding risk-factor modiﬁcation and follow-up, although
we have not established a strict follow-up imaging schedule
for this group of patients. Use of the EMRwill allow us to re-
screen this population in the future at an appropriate time in-
terval (most likely 5 years) if it is determined to bewarranted.
Finally, we did not have a strict policy for follow-up of
the portion of the screening population whose ultrasound
exams were non-diagnostic due to inability to image the
aorta. Practitioners were encouraged to order a noncon-
trast computed tomography scan, but this order was not
generated automatically.
CONCLUSIONS
In summary, in a large integrated health care system
such as Kaiser Permanente, a universally deployed EMR al-
lows for rapid development and institution of a screening
program for AAAs. This experience demonstrates the efﬁ-
cacy and immediate yield of this program in identifying pa-
tients with previously undetected AAAs and reducing the
number of unscreened patients in our members. Diagnosis
of patients with small AAAs and aortic ectasia also facilitates
implementation of cardiovascular risk-reduction strategies
and discussion with patients for this segment of our popu-
lation. We believe that others can implement similar
screening programs, particularly as EMR deployment is
increasing and more integrated systems are being created
such as Accountable Care Organizations. Acknowledging
that the decision to initiate our program with the weak-
nesses noted above has undoubtedly missed some AAAs,
on the whole, it is likely that far more patients have been
diagnosed with AAAs than would have otherwise been
detected. Overall, this has the potential to reduce the
morbidity and mortality associated with ruptured AAAs
in our organization. An analysis of the impact of the pro-
gram on AAA rupture rate is planned in the future. Finally,
it should be re-emphasized that the system we have estab-
lished is not a one-time or static approach; it can be modi-
ﬁed on an ongoing basis by varying the parameters that
trigger the “ﬁring” of the BPA. Therefore, the opportunity
exists to adjust future criteria for screening and follow-up
to minimize risk of missing some patients with AAAs.
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laborators in the San Diego-area Kaiser Permanente System have
achieved the seemingly unachievable e through modest tinkering
with their electronic medical record system, and a prodigious
commitment of imaging resources, they have reduced the number
of unscreened men at risk for early AAA-related death system-wide
by more than 50% within 15 months. This quality improvement
project was undertaken on their own initiative, on the basis of in-
ternal data suggesting an excessive rate of ruptured AAA, with buy-
in from radiologists and other signiﬁcant stakeholders. A truly
remarkable achievement, Bob, for which you are to be rightly
congratulated.
To place this accomplishment in its appropriate context, a few
facets deserve further elaboration by the authors.
First, was it worth it? The manuscript notes that it is too early
to determine whether the incidence of ruptured aneurysm will
decline, or survival improve following emergent repair, as a result
of more comprehensive compliance with screening guidelines.
But, are there sufﬁcient aneurysms in your population to justify
this effort?
The yield of this screening program in this “high-risk” popu-
lation was 1.3%, with only 0.3% of newly identiﬁed AAA > 4.0 cm.
Apparently, there are far fewer AAAs in your population than were
expected at the outset. As noted recently by Frank Lederle, AAA-
related death appears to be in steep decline in the last 20 years,
potentially as a function of declining numbers of cigarettes smoked
per capita by Americans since the 1970s , and it may well be that
current screening guidelines were developed for an “epidemic”
which no longer exists. Also, a recent report from the long-running
Chichester screening study in the UK suggests that as many as 50%
of AAA less than 3.5 cm in diameter do not enlarge further, at least
through 10 years in follow-up. Perhaps the deﬁnition of an AAA as
an aortic diameter greater than 3.0 cm needs to be revised for pur-
poses of preventative screening. To these points, Bob, what is the
prevalence of current vs ever-smokers in your population, and do
you have any insight into trends regarding changes in smoking in-
tensity over time? How would the yield improve if screening were
limited to current or recent smokers or those with a pack/year his-
tory over a certain threshold? What criteria would you use to iden-
tify women at risk, and are plans in place to implement those as
well?
Additionally, what role did other variables play in the observed
prevalence of ruptured AAA? Were there issues with access to care
for some Kaiser subscribers or follow-up of patients already known
or suspected of having AAA?Secondly, your protocol excluded potentially eligible patients
who had received prior abdominal imaging study within the past
10 years, although the results of those prior studies were not
reviewed in the context of this investigation. How was this 10-
year threshold determined? Experience from the UK Small Aneu-
rysm Trial suggests that patients with a sub 3-cm aortic diameter
by age 65 will never go on to develop clinically signiﬁcant AAA dis-
ease, but does that same relationship hold true for younger pa-
tients? What is the risk of later enlargement when the diameter is
3.0 cm or less at age 55, particularly in active smokers?
Did the “best practice alert” system become activated for any
patient visit, for any purpose, to any participating Kaiser facility
(eg, pharmacy visit, or physical therapy appointment, etc)? Now
that you have demonstrated feasibility within Kaiser generally,
what barriers exist to extending this system beyond the San Diego
area (eg, Northern California or Hawaii)?
In summary, committed physicians and professional col-
leagues in the San Diego Kaiser system have demonstrated that,
through the miracle of modern information technology, dramatic
improvements in process measure compliance can be rapidly
achieved. Even though, at the outset, 50% of the at-risk population
were already receiving appropriate care, vast improvement was still
achievable through coordinated effort. Hopefully, this experience
can inform the larger U.S. health system regarding potential
best-practice approaches to guideline compliance. Thank you to
the Program Committee for allowing me to review and discuss
this ﬁne paper, and congratulations again to Dr Hye and his col-
leagues on a remarkable achievement.
Dr Robert J. Hye. I want to thank Dr Dalman for his kind
remarks and review of the manuscript. Before answering the ques-
tions, I want to emphasize that this project involved all of the KP
facilities in Southern California and not just San Diego. Addition-
ally, we did not think our AAA rupture rate was excessive so much
as we felt that many were preventable and part of the mission of
any health care system should be to minimize preventable deaths.
As you correctly point out, the million-dollar question is
whether this screening program is “worth it.” Unfortunately, we
don’t know yet, but our next project will be to determine that.
The current program was implemented largely using existing
personnel, so the major expense was related to the additional ultra-
sound studies. As you know, calculation of all the costs one needs
to consider in the ﬁnancial assessment is complicated.
The other aspect of this question is whether the yield of AAA
is adequate to justify the program. Admittedly, the yield of aneu-
rysms in our study is lower than that of most screening studies.
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versus remote smokers. There is an aggressive smoking cessation
program in KP SCAL and California has one of the lowest rates
of current smokers in the United States, so it is entirely possible
that most of our patients were remote smokers. Additionally, since
one of our selection criteria was the lack of an abdominal imaging
study within the past 10 years, the population selected for
screening probably represents a healthier group in general having
had fewer encounters for medical care. The yield may increase if
we limited screening to recent or current smokers or used a higher
pack-year threshold.
The question of changing the deﬁnition of AAA to a larger
size is interesting. We have had internal discussions regarding
how to manage the population with aortic ectasia and those with
small aneurysms. As you point out, the Chichester study did
show a relatively low rate of aneurysm expansion and suggested
that follow-up scan intervals might be individualized. In the Glou-
cestershire study, although many patients with aortic diameters less
than 3.5 cm did not enlarge in follow-up, 40% of patients with
initial aortic diameters between 3 and 3.9 cm underwent elective
repair within 10 years of screening. A recent meta-analysis also
showed size progression to over 5.4 cm in 26% of patients with
initial aortic diameters of 2.5 to 2.9 cm. I think it would be difﬁcult
to completely exclude patients with aortic diameters between 2.6
and 3.5 cm from follow-up at this point, although applying
some age criteria may be reasonable. We need better data to deter-
mine the appropriate rescreening intervals and whether those inter-
vals should be adjusted on the basis of age, aneurysm growth or
continued smoking.
I am not sure how to identify women at-risk beyond adding
additional factors such as family history or peripheral arterial dis-
ease. Women represented less than 20% of the patients withrupture in our internal review and have a lower prevalence of
AAA, so we do not currently plan to extend screening to females.
We do not believe that access to care was an issue in our prev-
alence of ruptured AAA. The majority of patients who ruptured
had undiagnosed AAA and only a few had had known AAA with
failed follow-up. Our organization does not mandate that patients
have yearly exams, but elderly patients are encouraged to see their
primary care physician regularly, particularly if they have cardiovas-
cular risk factors.
The decision to use 10 years without an abdominal imaging
study as a criteria for screening eligibility was made by consensus
after careful consideration. We recognized that we might miss a
few patients but felt that the yield of AAA in the group with prior
imaging would be low. We also felt that the additional resources
required if we were to review those patients’ studies could not
be justiﬁed. As mentioned in the manuscript, use of Natural Lan-
guage Processing software to review reports may be a way to add
some additional certainty regarding that group.
The “best practice alert” was activated for any physician or
physician extender visit at any KP SCAL facility. An order for a
screening aortic ultrasound is entered by back ofﬁce staff in the
chart of an eligible patient and then signed by the physician. Since
a signed physician order is required, extending the system to non-
provider visits would require a mechanism to generate the order
and obtain a signature. There are no real barriers to implementa-
tion of this system in other Kaiser regions, but Kaiser in Northern
California has generally elected not to use “best practice alerts”.
KP in Hawaii and the Paciﬁc Northwest have screening programs
in place with the latter using the BPA mechanism.
Thank you again for the thoughtful review and we look for-
ward to examining the cost and clinical effectiveness of this pro-
gram for a future presentation.
